￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Xalkori has very good results in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Application of Xalkori (crizotinib) in ROS1-rearranged non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Can all cancers with NTRK gene fusions be treated with larotrectinib?

2025-10-19 11:44:20

Check Details
How much does a box of larotrectinib cost? Do you have medical insurance?

2025-10-19 11:44:20

Check Details
Efficacy and Safety of Crizotinib (Xalkori) in Patients with Lung Cancer

2025-10-19 11:44:20

Check Details
Will larotrectinib be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Where can I buy larotrectinib in China? How much does a box cost?

2025-10-19 11:44:20

Check Details
Can the broad-spectrum anticancer drug larotrectinib be reimbursed by medical insurance?

2025-10-19 11:44:20

Check Details
Can cabozantinib (XL184) improve quality of life in metastatic RCC?

2025-10-19 11:44:20

Check Details
Data on the efficacy of larotrectinib in the treatment of NTRK-positive lung cancer

2025-10-19 11:44:20

Check Details
Precautions for using larotinib in patients with lung cancer

2025-10-19 11:44:20

Check Details
The cost of larotrectinib treatment for lung cancer _ Kanghule

2025-10-19 11:44:20

Check Details
Category
相关知识